ClinConnect ClinConnect Logo
Search / Trial NCT06924073

Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV

Launched by UNIVERSITY OF WASHINGTON · Apr 4, 2025

Trial Information

Current as of August 23, 2025

Not yet recruiting

Keywords

Adolescent Hiv Transition To Adult Care Scale Up Implementation Science Implementation Strategy

ClinConnect Summary

This clinical trial is focused on improving how young people living with HIV transition from pediatric to adult healthcare. It aims to test a new approach, led by youth themselves, to help make sure that these young people get the support they need during this important change. The trial will compare two different strategies at clinics in Kenya: one that uses standard training for healthcare providers and another that includes a youth-led initiative to enhance the transition process. The goal is to see if the new approach helps more young people receive necessary care, improves their health outcomes, and encourages healthcare providers to consistently use the transition support package being tested.

To participate in this study, healthcare providers must be at least 18 years old and work at one of the participating clinics. They need to provide HIV services to adolescents. Young people aged 10-24 who are living with HIV and receiving care at these clinics may also be eligible. Participants can expect to take part in surveys and focus group discussions, and their medical records will be reviewed to track how well the transition support package works over time. This study is not yet recruiting participants, but it aims to gather valuable information that could lead to better care for young people living with HIV.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthcare providers
  • ≥18 years of age
  • Employed at one of the 32 facilities in the RCT
  • Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
  • Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
  • Receives HIV clinical care at one of the clinics included in the study
  • Attended clinic ≥1 time following intervention implementation
  • Exclusion Criteria:
  • Any individual who meets the following criteria will be excluded from participation in this study:
  • - Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Nairobi, , Kenya

Patients applied

0 patients applied

Trial Officials

Kristin M Beima-Sofie, PhD, MPH

Principal Investigator

University of Washington

Irene Njuguna, MBChB, MPH, PhD

Principal Investigator

Kenyatta National Hospital

Grace John-Stewart, MD, PhD, MPH

Principal Investigator

University of Washington

Dalton Wamalwa, MBChB, MMed, MPH

Principal Investigator

University of Nairobi

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported